Position in CGEM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,453,115
+$658,553 QoQ
Shares Held
243,006
-10.0% QoQ
Ownership
0.378%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGEM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $630,516,329 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
6,776,632 | $343,914,074 | |
| 3 | MBX |
MBX Biosciences, Inc.
|
3,428,736 | $189,266,227 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
2,209,400 | $118,578,498 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
2,555,877 | $112,433,029 | |
| 6 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $107,045,189 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
3,027,328 | $105,169,374 | |
| 8 | ARGX |
Argenx SE
|
92,880 | $86,171,277 |
All Filings in CGEM
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,453,115 | 243,006 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,794,562 | 270,006 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,408,460 | 1,923,855 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $14,486,628 | 1,923,855 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,563,582 | 1,923,855 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $23,660,319 | 1,942,555 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $17,912,720 | 1,070,055 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $20,015,103 | 1,147,655 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,820,006 | 517,606 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,552,001 | 544,848 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,930,874 | 544,848 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,862,564 | 544,848 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,193,109 | 605,387 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,723,377 | 637,287 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,170,019 | 637,287 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,599,489 | 670,787 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,023,139 | 670,787 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $12,421,782 | 805,041 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $25,868,492 | 1,146,145 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $29,513,233 | 1,146,145 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $47,759,862 | 1,146,145 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||